National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Estrogen Receptors/SERMs
< Back to Main
    Posted: 01/28/2005    Updated: 04/27/2006    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
PowerPoint Version  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Estrogen Receptors/SERMs

      Slide Number and Title
  1. What Are Estrogens?
  2. Estrogen Target Tissues
  3. Estrogen Receptors
  4. Estrogen Receptors Trigger Gene Activation
  5. Estrogen-Induced Changes in Cell Behavior
  6. Estrogen-Induced Stimulation of Cell Proliferation
  7. Estrogen and Cancer
  8. Estrogen and Breast Cancer
  9. Cancer Arises From DNA Mutations In Cells
  10. Estrogen-Induced Proliferation of Existing Mutant Cells
  11. Estrogen-Induced Proliferation and Spontaneous New Mutations
  12. Estrogen and Uterine Cancer
  13. Antiestrogens
     
  1. SERMs
  2. Tamoxifen and Cancer
  3. Tamoxifen and Breast Cancer Treatment
  4. Estrogen Receptor-Negative Breast Cancer
  5. Tamoxifen and Breast Cancer Prevention
  6. Tamoxifen as a Cause of Uterine Cancer
  7. The Need for Better SERMs
  8. Estrogen Replacement During Menopause
  9. Estrogen Plus Progesterone Replacement
  10. Search for the Perfect SERM
  11. Raloxifene and the Prevention of Osteoporosis
  12. Raloxifene and Risk of Invasive Breast Cancer

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov